CAPR News

CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026 Ready to Announce with Confidence?

INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Capricor Class Action Lawsuit - CAPR

Investors Urged to Contact Levi & Korsinsky for Information Before September 28, 2026 - Capricor Therapeutics, Inc. (CAPR)

CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors

Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 28, 2026 – Contact Levi & Korsinsky

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) Over Securities Violations - Contact Levi & Korsinsky Today

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR